Matches in SemOpenAlex for { <https://semopenalex.org/work/W3015655241> ?p ?o ?g. }
Showing items 1 to 88 of
88
with 100 items per page.
- W3015655241 endingPage "475" @default.
- W3015655241 startingPage "469" @default.
- W3015655241 abstract "ABSTRACT In people with type 2 diabetes with evidence of obesity-related insulin resistance, use of insulin to treat hyperglycemia has not been shown to reduce macrovascular complications, despite widespread use for many years. However, newer classes of diabetes medications, designed to address the prevalent pathophysiologic defect of type 2 diabetes, have emerged. Consequently, in many patients, reduction of insulin doses or even total elimination is possible after the addition of these newer agents. The authors suggest a cautious approach in which people with type 2 diabetes and established cardiovascular disease who are on high insulin doses (>1.0 unit/kg/day) be treated with diabetes medications that showed evidence of cardiovascular benefit (such as glucagon-like peptide-1 receptor agonists [GLP-1RAs]), on whom close monitoring is crucial because they may be at particular risk for developing hypoglycemia. This approach can be labor intensive and may be challenging for busy primary care providers for who may have limited time to evaluate and follow the patient. The authors present a case report of adding a GLP-1RA to high insulin doses. If the hemoglobin A1c is <8.0% when GLP-1RA is added, insulin doses should be reduced by 20%. Patients should be monitored at least every 4 weeks initially until it is confirmed there is no hypoglycemia risk. If glycemic targets (defined as fasting or preprandial glucose level between 80 and 130 mg/dl) are consistently achieved, providers may consider proactively reducing insulin doses by 10–20% to avoid hypoglycemia. The authors recommend creating appropriate goals and expectation before initiating this process." @default.
- W3015655241 created "2020-04-17" @default.
- W3015655241 creator A5005950432 @default.
- W3015655241 creator A5008174167 @default.
- W3015655241 creator A5027721713 @default.
- W3015655241 creator A5062407829 @default.
- W3015655241 creator A5085226290 @default.
- W3015655241 date "2020-06-01" @default.
- W3015655241 modified "2023-09-26" @default.
- W3015655241 title "Transitioning to non-insulin therapy in a patient receiving high dose insulin" @default.
- W3015655241 cites W172609984 @default.
- W3015655241 cites W2000443574 @default.
- W3015655241 cites W2002908162 @default.
- W3015655241 cites W2078839892 @default.
- W3015655241 cites W2171843668 @default.
- W3015655241 cites W2191272310 @default.
- W3015655241 cites W2292172438 @default.
- W3015655241 cites W2337454357 @default.
- W3015655241 cites W2397499320 @default.
- W3015655241 cites W2415124771 @default.
- W3015655241 cites W2425644022 @default.
- W3015655241 cites W2519510391 @default.
- W3015655241 cites W2521422828 @default.
- W3015655241 cites W2695892839 @default.
- W3015655241 cites W2757748853 @default.
- W3015655241 cites W2791169690 @default.
- W3015655241 cites W2801715295 @default.
- W3015655241 cites W2892305139 @default.
- W3015655241 cites W2894746763 @default.
- W3015655241 cites W2894993577 @default.
- W3015655241 cites W2895533920 @default.
- W3015655241 cites W2897325487 @default.
- W3015655241 cites W2915807915 @default.
- W3015655241 cites W2948261890 @default.
- W3015655241 cites W2959825751 @default.
- W3015655241 doi "https://doi.org/10.1097/jxx.0000000000000403" @default.
- W3015655241 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32282568" @default.
- W3015655241 hasPublicationYear "2020" @default.
- W3015655241 type Work @default.
- W3015655241 sameAs 3015655241 @default.
- W3015655241 citedByCount "0" @default.
- W3015655241 crossrefType "journal-article" @default.
- W3015655241 hasAuthorship W3015655241A5005950432 @default.
- W3015655241 hasAuthorship W3015655241A5008174167 @default.
- W3015655241 hasAuthorship W3015655241A5027721713 @default.
- W3015655241 hasAuthorship W3015655241A5062407829 @default.
- W3015655241 hasAuthorship W3015655241A5085226290 @default.
- W3015655241 hasConcept C126322002 @default.
- W3015655241 hasConcept C134018914 @default.
- W3015655241 hasConcept C177713679 @default.
- W3015655241 hasConcept C2777180221 @default.
- W3015655241 hasConcept C2777391703 @default.
- W3015655241 hasConcept C2779306644 @default.
- W3015655241 hasConcept C2780473172 @default.
- W3015655241 hasConcept C2780668416 @default.
- W3015655241 hasConcept C555293320 @default.
- W3015655241 hasConcept C71924100 @default.
- W3015655241 hasConceptScore W3015655241C126322002 @default.
- W3015655241 hasConceptScore W3015655241C134018914 @default.
- W3015655241 hasConceptScore W3015655241C177713679 @default.
- W3015655241 hasConceptScore W3015655241C2777180221 @default.
- W3015655241 hasConceptScore W3015655241C2777391703 @default.
- W3015655241 hasConceptScore W3015655241C2779306644 @default.
- W3015655241 hasConceptScore W3015655241C2780473172 @default.
- W3015655241 hasConceptScore W3015655241C2780668416 @default.
- W3015655241 hasConceptScore W3015655241C555293320 @default.
- W3015655241 hasConceptScore W3015655241C71924100 @default.
- W3015655241 hasIssue "6" @default.
- W3015655241 hasLocation W30156552411 @default.
- W3015655241 hasOpenAccess W3015655241 @default.
- W3015655241 hasPrimaryLocation W30156552411 @default.
- W3015655241 hasRelatedWork W138803513 @default.
- W3015655241 hasRelatedWork W1979252938 @default.
- W3015655241 hasRelatedWork W1983641721 @default.
- W3015655241 hasRelatedWork W1986132654 @default.
- W3015655241 hasRelatedWork W2010140898 @default.
- W3015655241 hasRelatedWork W2026226896 @default.
- W3015655241 hasRelatedWork W2082140668 @default.
- W3015655241 hasRelatedWork W2169206971 @default.
- W3015655241 hasRelatedWork W2584731720 @default.
- W3015655241 hasRelatedWork W4234612679 @default.
- W3015655241 hasVolume "32" @default.
- W3015655241 isParatext "false" @default.
- W3015655241 isRetracted "false" @default.
- W3015655241 magId "3015655241" @default.
- W3015655241 workType "article" @default.